Transite Technology

Transite Technology is a biotechnology company specializing in the isolation and analysis of extracellular vesicles (EVs) for liquid biopsy applications. The company utilizes a proprietary platform designed to capture EVs with high purity and efficiency from complex biological samples like blood. By enabling precise molecular profiling of EVs, Transite aims to improve early-stage disease detection and therapeutic monitoring, particularly in oncology. The technology is positioned to replace traditional, labor-intensive isolation methods with a scalable, automated solution suitable for clinical and research settings. The company was founded by researchers from Stanford University to bridge the gap between EV research and clinical diagnostics.